WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma

Phase 2

Active, not recruiting

Conditions: Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma
Cancer of the Head and Neck

Interventions: Drug: nab-paclitaxel
Drug: Cisplatin
Drug: Carboplatin
Biological: Cetuximab

First Posted Date: 2014-10-21

Last Posted Date: 2024-12-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 74

Registration Number: NCT02270814

Locations: 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸
Sanford Cancer Center Oncology Clinic and Pharmacy, Sioux Falls, South Dakota, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

and more 2 locations

Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies

Phase 1

Completed

Conditions: Liver Cancer
Non-Liver Abdominal Cancer
Central Thorax Cancer

Interventions: Radiation: MRI-guided stereotactive body radiation therapy

First Posted Date: 2014-10-15

Last Posted Date: 2016-12-09

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 30

Registration Number: NCT02264886

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Combined Package of Interventions for Environmental Enteropathy

Not Applicable

Completed

Conditions: Environmental Enteropathy

Interventions: Drug: Placebo
Drug: Albendazole
Dietary Supplement: Zinc
Dietary Supplement: Multiple Micronutrient Supplement

First Posted Date: 2014-10-01

Last Posted Date: 2015-06-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 253

Registration Number: NCT02253095

Locations: 🇲🇼
Limela Rural Site, Limela, Machinga Distric, Malawi

Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma

Phase 2

Active, not recruiting

Conditions: Multiple Myeloma

Interventions: Biological: Ixazomib
Drug: Lenalidomide
Drug: Dexamethasone

First Posted Date: 2014-10-01

Last Posted Date: 2024-10-01

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 236

Registration Number: NCT02253316

Locations: 🇺🇸
Karmanos Cancer Institute, Detroit, Michigan, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States

and more 7 locations

Electroencephalography Guidance of Anesthesia

Not Applicable

Conditions: Delirium

Interventions: Device: a pragmatic EEG-guided anesthetic protocol

First Posted Date: 2014-09-16

Last Posted Date: 2019-07-30

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1400

Registration Number: NCT02241655

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Reduction of Excessive Calories From Beverages in Children

Not Applicable

Completed

Conditions: Unhealthy Diet

Interventions: Behavioral: Physician communication

First Posted Date: 2014-09-15

Last Posted Date: 2018-10-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 443

Registration Number: NCT02239653

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Intensive Case Diabetes Management (ICDM) to Prevent Readmission

Not Applicable

Terminated

Conditions: Diabetes

Interventions: Other: Intensive Diabetes Case Management

First Posted Date: 2014-09-03

Last Posted Date: 2015-06-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1

Registration Number: NCT02230488

Locations: 🇺🇸
Barnes-Jewish Hospital, St. Louis, Missouri, United States

Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma

Phase 1

Completed

Conditions: Multiple Myeloma

Interventions: Biological: Bortezomib
Drug: G-CSF

First Posted Date: 2014-08-20

Last Posted Date: 2018-01-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 10

Registration Number: NCT02220608

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Alvimopan and Ileus in PSF

Not Applicable

Completed

Conditions: Ileus
Spinal Fusion

Interventions: Drug: Alvimopan
Drug: Placebo

First Posted Date: 2014-08-18

Last Posted Date: 2019-05-17

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 31

Registration Number: NCT02218190

Locations: 🇺🇸
Barnes Jewish Hospital / Washington University in St. Louis School of Medicine, Saint Louis, Missouri, United States

Tumor: Breast Ratio Study

Completed

Conditions: Breast Cancer
DCIS
LCIS

First Posted Date: 2014-08-13

Last Posted Date: 2019-08-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 162

Registration Number: NCT02216136

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy